These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 31733323)
1. Stereotactic Body Radiation Therapy to the Prostate Bed: Results of a Phase 1 Dose-Escalation Trial. Sampath S; Frankel P; Vecchio BD; Ruel N; Yuh B; Liu A; Tsai T; Wong J Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):537-545. PubMed ID: 31733323 [TBL] [Abstract][Full Text] [Related]
2. A Phase 1 Trial of Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer After Brachytherapy. Patel KR; Rydzewski NR; Schott E; Cooley-Zgela T; Ning H; Cheng J; Salerno K; Huang EP; Lindenberg L; Mena E; Choyke P; Turkbey B; Citrin DE Int J Radiat Oncol Biol Phys; 2024 Aug; 119(5):1471-1480. PubMed ID: 38428681 [TBL] [Abstract][Full Text] [Related]
3. Outcomes of a Dose-Escalated Stereotactic Body Radiation Phase 1 Trial for Patients With Low- and Intermediate-Risk Prostate Cancer. Potters L; Rana Z; Lee L; Cox BW Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):334-342. PubMed ID: 30721721 [TBL] [Abstract][Full Text] [Related]
4. Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer. Boike TP; Lotan Y; Cho LC; Brindle J; DeRose P; Xie XJ; Yan J; Foster R; Pistenmaa D; Perkins A; Cooley S; Timmerman R J Clin Oncol; 2011 May; 29(15):2020-6. PubMed ID: 21464418 [TBL] [Abstract][Full Text] [Related]
5. Retreatment for Local Recurrence of Prostatic Carcinoma After Prior Therapeutic Irradiation: Efficacy and Toxicity of HDR-Like SBRT. Fuller D; Wurzer J; Shirazi R; Bridge S; Law J; Crabtree T; Mardirossian G Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):291-299. PubMed ID: 31629838 [TBL] [Abstract][Full Text] [Related]
6. Long-term Outcomes from a Phase 1 Dose Escalation Study Using Stereotactic Body Radiotherapy for Patients with Low- or Intermediate-risk Prostate Cancer. Moore A; Kollmeier MA; McBride SM; Toumbacaris N; Zhang Z; Lacy-Elsayegh A; Dreyfuss A; Grossman CE; Gorovets D; Zelefsky MJ Eur Urol Oncol; 2024 Aug; 7(4):812-820. PubMed ID: 37949730 [TBL] [Abstract][Full Text] [Related]
7. 50-Gy Stereotactic Body Radiation Therapy to the Dominant Intraprostatic Nodule: Results From a Phase 1a/b Trial. Herrera FG; Valerio M; Berthold D; Tawadros T; Meuwly JY; Vallet V; Baumgartner P; Thierry AC; De Bari B; Jichlinski P; Kandalaft L; Coukos G; Harari A; Bourhis J Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):320-334. PubMed ID: 30267761 [TBL] [Abstract][Full Text] [Related]
8. Early Tolerance and Tumor Control Outcomes with High-dose Ultrahypofractionated Radiation Therapy for Prostate Cancer. Zelefsky MJ; Pinitpatcharalert A; Kollmeier M; Goldman DA; McBride S; Gorovets D; Zhang Z; Varghese M; Happersett L; Tyagi N; Hunt M Eur Urol Oncol; 2020 Dec; 3(6):748-755. PubMed ID: 31668713 [TBL] [Abstract][Full Text] [Related]
9. Interim Results of a Prospective Prostate-Specific Membrane Antigen-Directed Focal Stereotactic Reirradiation Trial for Locally Recurrent Prostate Cancer. Bergamin S; Eade T; Kneebone A; Booth J; Hsiao E; Schembri GP; Szymura K; Le A; Kwong C; Brown C; Hunter J; Hruby G Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1172-1178. PubMed ID: 32659332 [TBL] [Abstract][Full Text] [Related]
10. Phase 1 Trial of SBRT to the Prostate Fossa After Prostatectomy. Ballas LK; Luo C; Chung E; Kishan AU; Shuryak I; Quinn DI; Dorff T; Jhimlee S; Chiu R; Abreu A; Jennelle R; Aron M; Groshen S Int J Radiat Oncol Biol Phys; 2019 May; 104(1):50-60. PubMed ID: 30605751 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous Focal Boost With Stereotactic Radiation Therapy for Localized Intermediate- to High-Risk Prostate Cancer: Primary Outcomes of the SPARC Phase 2 Trial. Yasar B; Suh YE; Chapman E; Nicholls L; Henderson D; Jones C; Morrison K; Wells E; Henderson J; Meehan C; Sohaib A; Taylor H; Tree A; van As N Int J Radiat Oncol Biol Phys; 2024 Sep; 120(1):49-58. PubMed ID: 38499253 [TBL] [Abstract][Full Text] [Related]
12. Five-Year Outcomes of a Phase 1 Dose-Escalation Study Using Stereotactic Body Radiosurgery for Patients With Low-Risk and Intermediate-Risk Prostate Cancer. Zelefsky MJ; Kollmeier M; McBride S; Varghese M; Mychalczak B; Gewanter R; Garg MK; Happersett L; Goldman DA; Pei I; Lin M; Zhang Z; Cox BW Int J Radiat Oncol Biol Phys; 2019 May; 104(1):42-49. PubMed ID: 30611838 [TBL] [Abstract][Full Text] [Related]
13. Stereotactic Body Radiation Therapy Boost for Intermediate-Risk Prostate Cancer: A Phase 1 Dose-Escalation Study. Alayed Y; Loblaw A; Chu W; Al-Hanaqta M; Chiang A; Jain S; Chung H; Vesprini D; Morton G; Ravi A; Davidson M; Deabreu A; Mamedov A; Zhang L; Erler D; Cheung P Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1066-1073. PubMed ID: 31002941 [TBL] [Abstract][Full Text] [Related]
14. Increased toxicities associated with dose escalation of stereotactic body radiation therapy in prostate cancer: results from a phase I/II study. Hirata T; Suzuki O; Otani K; Miyake A; Tamari K; Seo Y; Isohashi F; Kai N; Hatano K; Fujita K; Uemura M; Imamura R; Tamenaga S; Yoshino Y; Fumimoto Y; Yoshioka Y; Nonomura N; Ogawa K Acta Oncol; 2023 May; 62(5):488-494. PubMed ID: 37203203 [TBL] [Abstract][Full Text] [Related]
15. High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: Preliminary prostate-specific antigen response, disease-free survival, and toxicity assessment. Fuller DB; Wurzer J; Shirazi R; Bridge SS; Law J; Mardirossian G Pract Radiat Oncol; 2015; 5(6):e615-23. PubMed ID: 26059509 [TBL] [Abstract][Full Text] [Related]
16. Salvage Stereotactic Body Radiation Therapy for Local Prostate Cancer Recurrence After Radiation Therapy: A Retrospective Multicenter Study of the GETUG. Pasquier D; Martinage G; Janoray G; Rojas DP; Zerini D; Goupy F; De Crevoisier R; Bogart E; Calais G; Toledano A; Chauveinc L; Scher N; Bondiau PY; Hannoun-Levi JM; Silva M; Meyer E; Nickers P; Lacornerie T; Jereczek-Fossa BA; Lartigau E Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):727-734. PubMed ID: 31344433 [TBL] [Abstract][Full Text] [Related]
17. The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study. Pasquier D; Lacornerie T; Supiot S; Pommier P; Quivrin M; Simon JM; Loos G; Meyer E; Calais G; Peiffert D; Vandendorpe B; Aymes E; Leguillette C; Brihoum M; Nenan S; Cormier L; Le Deley MC; Lartigau EF Eur Urol Oncol; 2023 Aug; 6(4):399-405. PubMed ID: 36754722 [TBL] [Abstract][Full Text] [Related]
18. Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10. Ghadjar P; Hayoz S; Bernhard J; Zwahlen DR; Hölscher T; Gut P; Guckenberger M; Hildebrandt G; Müller AC; Plasswilm L; Papachristofilou A; Stalder L; Biaggi-Rudolf C; Sumila M; Kranzbühler H; Najafi Y; Ost P; Azinwi NC; Reuter C; Bodis S; Kaouthar K; Wust P; Thalmann GN; Aebersold DM J Clin Oncol; 2015 Dec; 33(35):4158-66. PubMed ID: 26527774 [TBL] [Abstract][Full Text] [Related]
19. Quality-of-Life Outcomes and Toxicity Profile Among Patients With Localized Prostate Cancer After Radical Prostatectomy Treated With Stereotactic Body Radiation: The SCIMITAR Multicenter Phase 2 Trial. Ma TM; Ballas LK; Wilhalme H; Sachdeva A; Chong N; Sharma S; Yang T; Basehart V; Reiter RE; Saigal C; Chamie K; Litwin MS; Rettig MB; Nickols NG; Yoon SM; Smith L; Gao Y; Steinberg ML; Cao M; Kishan AU Int J Radiat Oncol Biol Phys; 2023 Jan; 115(1):142-152. PubMed ID: 36007724 [TBL] [Abstract][Full Text] [Related]
20. Reirradiation of Locally Recurrent Prostate Cancer With Volumetric Modulated Arc Therapy. D'Agostino GR; Di Brina L; Mancosu P; Franzese C; Iftode C; Franceschini D; Clerici E; Tozzi A; Navarria P; Scorsetti M Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):614-621. PubMed ID: 30825495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]